Pfizer Most Affected by G1 Rule, 8 Off-Patent APIs Go into This Category: Jiho Survey

Pfizer Japan has the largest number of off-patent APIs to be categorized as “G1” under the 2020 drug price revision next month, at eight (24 products), with their prices to be brought down to 2.5 times their average generic prices,...read more